Top Markets
Coin of the day
Annovis Bio, Inc. Annovis Bio, Inc.

Annovis Bio, Inc.

ANVS
Rangering i aksjer #23205
Annovis Bio, Inc. is a clinical-stage biopharmaceutical company focused on... Annovis Bio, Inc. is a clinical-stage biopharmaceutical company focused on pioneering treatments for neurodegenerative disorders. The firm's flagship drug, Buntanetap, an oral medication, has successfully advanced through Phase 2a clinical trials for Alzheimer's and Parkinson's diseases. This compound is also currently being evaluated in clinical studies for Alzheimer's disease in individuals with Down Syndrome, as well as for various other chronic neurodegenerative conditions. Beyond Buntanetap, Annovis Bio is developing ANVS405 to offer protection against traumatic brain injury and stroke. Additionally, ANVS301 is progressing through Phase I clinical trials, aiming to enhance cognitive capabilities in the later stages of Alzheimer's disease and broader dementia. The company was founded in 2008 and operates out of Berwyn, Pennsylvania.
Aksjekurs
$1.81
Sist synkronisert: 2026-08-21
Markedsverdi
$77.00M
Endring (1 dag)
1.30%
Endring (1 år)
-23.63%
Land
US
Handel Annovis Bio, Inc. (ANVS)

Kategori

Historikk for aksjesplitt for Annovis Bio, Inc. (ANVS)
Aksjen Annovis Bio, Inc. (symbol: ANVS) har gjennomgått totalt 0 aksjesplitt.
Den nyeste splittelsen skjedde Aug 22, 2026.
Én ANVS-aksje kjøpt før Aug 22, 2026 tilsvarer i dag 0 ANVS-aksjer.
Liste over aksjesplitt
År Splitt Multiplikator Kumulativ multiplikator
Ikke nok data for de angitte datoene.
Aksjesplitt for lignende selskaper eller konkurrenter
Selskap Antall aksjesplitt Kumulativ multiplikator Land
1 x2
US
0 -
NL
0 -
US
1 x3
AU
0 -
CH